A comparative study of anxiety symptoms in Chinese and Rwandan adolescents: a cross-cultural measurement invariance study of the GAD-7 scale

中国和卢旺达青少年焦虑症状的比较研究:GAD-7量表的跨文化测量不变性研究

阅读:1

Abstract

INTRODUCTION: Cultural factors and assessment methods significantly influence how anxiety symptoms are expressed and reported. However, few cross-cultural studies have employed culturally appropriate and validated tools, and even fewer have provided substantial comparisons across different groups with diverse cultural backgrounds. This study aimed to assess the measurement invariance of the GAD-7 scale across Chinese and Rwandese adolescents, enabling reliable cross-cultural comparisons. METHODS: This study included 2017 Chinese adolescents and 1813 Rwandan adolescents. Cronbach's alpha, exploratory factor analysis (EFA), and multiple group confirmatory factor analysis (MGCFA) were used to assess the validity of the GAD-7 scale across the two groups. Measurement invariance testing was employed to investigate cross-cultural equivalence. RESULTS: The GAD-7 demonstrated good psychometric properties. CFA supported a one-factor model for the GAD-7 in both samples, though model fit indices varied. Measurement invariance testing confirmed configural and metric invariance but found partial scalar invariance. A latent mean comparison indicated a trend toward higher anxiety levels in Rwandan adolescents compared to Chinese adolescents, though the difference was not statistically significant (z = 0.02, d = 0.033, p = 0.98). DISCUSSION: The GAD-7 showed reliability in measuring generalized anxiety in both Chinese and Rwandese adolescents, confirming its cross-cultural construct validity. However, partial scalar invariance suggests that while the GAD-7 effectively detects anxiety symptoms, the severity of reported symptoms may not be directly comparable across cultures due to response patterns and possible linguistic factors. These findings highlight the importance of culturally sensitive instruments for accurate anxiety assessment and expand evidence on reliable symptom screening and treatment monitoring across diverse populations.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。